Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK.
Barts Health NHS Trust, London, UK.
Pain Pract. 2023 Nov;23(8):922-932. doi: 10.1111/papr.13262. Epub 2023 Jun 26.
Limb amputation can cause residual limb pain (RLP) and/or phantom limb pain (PLP). Although targeted muscle reinnervation (TMR) was initially introduced to facilitate the control of prosthetic limbs, it has been noted that these patients experience less pain and improved prosthetic functional outcomes. As a result, the use of TMR in managing neuroma-related RLP is increasing. The aim of this review is to assess the quality and strength of the evidence supporting the effectiveness of TMR in managing amputation-related pain.
Five different databases, including MEDLINE (PubMed), Scopus, Web of Science, Cochrane Library, and Embase, were searched from inception to March 2022. The protocol for this systematic review has been registered in the PROSPERO database (CRD42020218242). To be included, studies needed to compare pre- and postoperative pain outcomes or different techniques for adult patients who underwent TMR following amputation. Eligible studies also needed to use patient-reported outcome measures (PROMS) and be clinical trials or observational studies published in English. Excluded studies were case reports, case series, reviews, proof of concept studies, and conference proceedings. A meta-analysis was performed on studies that had similar intervention and control groups to examine treatment effects using a random-effects model. Studies were weighted using the inverse variance method, and a statistically significant p-value was considered to be less than or equal to 0.05.
This review included five studies for qualitative analysis and four studies for quantitative analysis. Reviewed studies enrolled a total of 127 patients. The TMR group was compared with standard treatment at 12 months follow-up. The TMR group showed significantly better PLP as assessed by the numerical rating score RLP, and PLP assessed using Patient-Reported Outcomes Measurement Information System (PROMIS) also showed significantly lower pain intensity in the TMR group.
There is limited evidence of good quality favoring TMR in reducing postamputation PLP and RLP pain compared with standard care. Randomized clinical trials are encouraged to compare the efficacy of different surgical techniques.
肢体截肢可导致残肢痛(RLP)和/或幻肢痛(PLP)。尽管靶向肌肉再支配(TMR)最初被引入以促进假肢控制,但已注意到这些患者疼痛减轻,假肢功能改善。因此,TMR 在治疗神经瘤相关 RLP 中的应用正在增加。本综述的目的是评估支持 TMR 在管理截肢相关疼痛方面有效性的证据的质量和强度。
从 2022 年 3 月开始,在 MEDLINE(PubMed)、Scopus、Web of Science、Cochrane 图书馆和 Embase 等五个不同数据库中进行了搜索。本系统评价的方案已在 PROSPERO 数据库(CRD42020218242)中注册。为了被纳入,研究需要比较 TMR 后成人患者的术前和术后疼痛结果或不同技术。合格的研究还需要使用患者报告的结果测量(PROMs),并以英文发表的临床试验或观察性研究。排除病例报告、病例系列、综述、概念验证研究和会议记录。对具有相似干预和对照组的研究进行了荟萃分析,以使用随机效应模型检查治疗效果。使用倒数方差法对研究进行加权,并且认为统计学上显著的 p 值小于或等于 0.05。
本综述包括五项定性分析研究和四项定量分析研究。回顾性研究共纳入 127 例患者。在 12 个月的随访中,TMR 组与标准治疗进行比较。TMR 组的数字评分量表 RLP 评估的 PLP 和 PROMIS 评估的 PLP 疼痛强度明显较低,TMR 组的 RLP 和 PLP 疼痛强度明显较低。
与标准护理相比,有质量较好的有限证据支持 TMR 可减少截肢后 PLP 和 RLP 疼痛。鼓励进行随机临床试验以比较不同手术技术的疗效。